CAS 2227197-38-6

Fórmula: C14H21N5

InChI: InChI=1S/C14H21N5/c1-10-5-7-18(2)8-12(10)19(3)14-11-4-6-15-13(11)16-9-17-14/h4,6,9-10,12H,5,7-8H2,1-3H3,(H,15,16,17)/t10-,12+/m1/s1

Chave InChI: UCFDYZNTNVHTGH-PWSUYJOCSA-N

SMILES: C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C

N-Methyl Tofacitinib Amine

CAS: 2227197-38-6

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi

Fórmula: C₁₄H₂₁N₅

Cor e Forma: Off-White Powder

Peso molecular: 259.1797

Ref: 45-1A20050

N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

CAS: 2227197-38-6

N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Fórmula: C₁₄H₂₁N₅

Pureza: 98%

Peso molecular: 259.36

Ref: 54-OR1036691

Tofacitinib Impurity 11

CAS: 2227197-38-6

Fórmula: C₁₄H₂₁N₅

Cor e Forma: White To Off-White Solid

Peso molecular: 259.36

Ref: 4Z-T-117038

N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

CAS: 2227197-38-6

Pureza: 98%

Peso molecular: 259.3569946

Ref: 10-F789628

Tofacitinib Impurity Y

CAS: 2227197-38-6

Fórmula: C₁₄H₂₁N₅

Peso molecular: 259.36

Ref: ST-EA-CP-T23067

(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine

CAS: 2227197-38-6

Fórmula: C₁₄H₂₁N₅

Pureza: 98%

Peso molecular: 259.3500

Ref: IN-DA00IKWZ